AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
Saved in:
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | Book |
| Language: | English |
| Published: |
Dhaka :
BME DEPT. MIST,
c2026.
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
- AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
- Drug Repurposing
- AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
- Approved: The Life Cycle of Drug Development
- IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
- IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH